SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Eloxx Pharmaceuticals, Inc. Common Stock

ELOX XNAS
$10.69 +0.04 (+0.38%) ▲ 15-min delayed
Open
$10.90
High
$10.94
Low
$9.90
Volume
15.0K
Market Cap
$43.69M

About Eloxx Pharmaceuticals, Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 7 Website →

Related Market News

No specific coverage for ELOX yet. Check out our latest market news or earnings calendar.

Get ELOX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Eloxx Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.